Sentient Bioscience's Seed Round

Sentient Bioscience raised a round of funding on September 22, 2009. Investors include Slater Technology Fund.

Sentient Bioscience makes technology in the field of embolization therapy, a system that limits blood supply to tumors without resorting to surgery. The tumor-blocking material also delivers targeted …

Articles about Sentient Bioscience's Seed Round: